We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.31B
AUM Growth
-$51.4M
Cap. Flow
-$54.7M
Cap. Flow %
-4.18%
Top 10 Hldgs %
12.11%
Holding
1,682
New
422
Increased
338
Reduced
347
Closed
506

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$18.2M
2
TER icon
Teradyne
TER
+$15.9M
3
BE icon
Bloom Energy
BE
+$15.3M
4
CYBR
CyberArk
CYBR
+$15.2M
5
EXAS
Exact Sciences
EXAS
+$13.4M

Sector Composition

Rank Sector Weight
1 Technology 22.29%
2 Healthcare 14.62%
3 Consumer Discretionary 10.89%
4 Industrials 8.81%
5 Communication Services 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UDR icon
1601
UDR
UDR
$12.3B
-57,600
Closed -$2.11M
UHS icon
1602
Universal Health Services
UHS
$10.2B
-5,819
Closed -$1.27M
ULBI icon
1603
Ultralife
ULBI
$86.4M
-11,641
Closed -$66.6K
UNH icon
1604
UnitedHealth
UNH
$376B
-2,711
Closed -$895K
UNM icon
1605
Unum
UNM
$13.6B
-3,194
Closed -$248K
URI icon
1606
United Rentals
URI
$67.2B
-303
Closed -$245K
USFD icon
1607
US Foods
USFD
$22.2B
-2,739
Closed -$206K
USLM icon
1608
United States Lime & Minerals
USLM
$3.16B
-1,713
Closed -$205K
UTZ icon
1609
Utz Brands
UTZ
$1.25B
-11,385
Closed -$118K
UUUU icon
1610
Energy Fuels
UUUU
$2.86B
-65,900
Closed -$958K
VCLT icon
1611
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
-4,050
Closed -$307K
VEEV icon
1612
Veeva Systems
VEEV
$33.1B
-2,585
Closed -$577K
VEON icon
1613
VEON
VEON
$3.62B
-3,977
Closed -$209K
VFC icon
1614
VF Corp
VFC
$5.63B
-25,367
Closed -$459K
VICI icon
1615
VICI Properties
VICI
$29B
-10,581
Closed -$298K
VIRT icon
1616
Virtu Financial
VIRT
$5.11B
-10,336
Closed -$344K
VMC icon
1617
Vulcan Materials
VMC
$34.8B
-710
Closed -$203K
VNDA icon
1618
Vanda Pharmaceuticals
VNDA
$307M
-15,100
Closed -$133K
VNT icon
1619
Vontier
VNT
$4.52B
-6,579
Closed -$245K
VRTX icon
1620
Vertex Pharmaceuticals
VRTX
$121B
-463
Closed -$210K
VST icon
1621
Vistra
VST
$50B
-2,758
Closed -$445K
VTR icon
1622
Ventas
VTR
$48B
-6,302
Closed -$488K
VZLA
1623
Vizsla Silver
VZLA
$1.1B
-34,489
Closed -$189K
WAB icon
1624
Wabtec
WAB
$49.1B
-1,669
Closed -$356K
WELL icon
1625
Welltower
WELL
$169B
-1,382
Closed -$257K

Similar funds

Prelude Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Prelude Capital Management held 1,682 positions worth $1.31B, down 3.8% from $1.36B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $54.7M in Q1 2026, closing 506 positions and reducing 347 holdings. Its most notable exit was CyberArk, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Appian worth $9.41M.

  • Prelude Capital Management's largest Q1 2026 buy was Appian: 390,321 shares worth $9.41M.
  • Prelude Capital Management added most to Penumbra in Q1 2026, an estimated $15.3M increase.
  • Prelude Capital Management's biggest Q1 2026 reduction was SPDR Gold Trust, cutting an estimated $18.2M.
  • Prelude Capital Management fully exited CyberArk in Q1 2026, selling an estimated $15.2M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.31B portfolio in Q1 2026.
  • Prelude Capital Management opened 422 new positions and closed 506 in Q1 2026.
  • Prelude Capital Management's portfolio value fell 3.8% quarter-over-quarter to $1.31B.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.